questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Hypersensibilité retardée : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypersensibilité retardée : Questions médicales les plus fréquentes",
"headline": "Hypersensibilité retardée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypersensibilité retardée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité",
"url": "https://questionsmedicales.fr/mesh/D006967",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité",
"code": {
"@type": "MedicalCode",
"code": "D006967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Eczéma de contact allergique",
"alternateName": "Dermatitis, Allergic Contact",
"url": "https://questionsmedicales.fr/mesh/D017449",
"about": {
"@type": "MedicalCondition",
"name": "Eczéma de contact allergique",
"code": {
"@type": "MedicalCode",
"code": "D017449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dermatite photoallergique",
"alternateName": "Dermatitis, Photoallergic",
"url": "https://questionsmedicales.fr/mesh/D017454",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite photoallergique",
"code": {
"@type": "MedicalCode",
"code": "D017454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dermatite de contact au Rhus toxicodendron",
"alternateName": "Dermatitis, Toxicodendron",
"url": "https://questionsmedicales.fr/mesh/D011040",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite de contact au Rhus toxicodendron",
"code": {
"@type": "MedicalCode",
"code": "D011040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"alternateName": "Sarcoidosis",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"url": "https://questionsmedicales.fr/mesh/D017565",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uvéoparotidite",
"alternateName": "Uveoparotid Fever",
"url": "https://questionsmedicales.fr/mesh/D014608",
"about": {
"@type": "MedicalCondition",
"name": "Uvéoparotidite",
"code": {
"@type": "MedicalCode",
"code": "D014608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.865"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée",
"alternateName": "Hypersensitivity, Delayed",
"code": {
"@type": "MedicalCode",
"code": "D006968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth J Phillips",
"url": "https://questionsmedicales.fr/author/Elizabeth%20J%20Phillips",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org."
}
},
{
"@type": "Person",
"name": "Shuen-Iu Hung",
"url": "https://questionsmedicales.fr/author/Shuen-Iu%20Hung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw."
}
},
{
"@type": "Person",
"name": "Andrew Gibson",
"url": "https://questionsmedicales.fr/author/Andrew%20Gibson",
"affiliation": {
"@type": "Organization",
"name": "Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia."
}
},
{
"@type": "Person",
"name": "Chuang-Wei Wang",
"url": "https://questionsmedicales.fr/author/Chuang-Wei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Wen-Hung Chung",
"url": "https://questionsmedicales.fr/author/Wen-Hung%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Kinetin induces microtubular breakdown, cell cycle arrest and programmed cell death in tobacco BY-2 cells.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36239807",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00709-022-01814-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36445551",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12032-022-01883-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells.",
"datePublished": "2022-09-11",
"url": "https://questionsmedicales.fr/article/36185334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7150/ijms.76623"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer Cells.",
"datePublished": "2024-02-14",
"url": "https://questionsmedicales.fr/article/38235946",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cbdv.202301645"
}
},
{
"@type": "ScholarlyArticle",
"name": "ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35654870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10495-022-01736-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypersensibilité retardée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypersensibilité retardée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypersensibilité retardée",
"description": "Comment diagnostiquer l'hypersensibilité retardée ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent une hypersensibilité retardée ?\nPeut-on diagnostiquer par des analyses sanguines ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypersensibilité retardée",
"description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes systémiques ?\nComment se manifeste une réaction cutanée ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypersensibilité retardée",
"description": "Comment prévenir l'hypersensibilité retardée ?\nLes tests d'allergie aident-ils à la prévention ?\nLes changements de mode de vie sont-ils nécessaires ?\nLes médicaments préventifs sont-ils disponibles ?\nComment gérer les expositions accidentelles ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypersensibilité retardée",
"description": "Quel est le traitement principal de l'hypersensibilité retardée ?\nLes antihistaminiques sont-ils efficaces ?\nComment les corticostéroïdes aident-ils ?\nY a-t-il des traitements topiques recommandés ?\nLes traitements sont-ils différents pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypersensibilité retardée",
"description": "Quelles complications peuvent survenir ?\nL'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque d'anaphylaxie ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypersensibilité retardée",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque d'hypersensibilité ?\nLes professions exposées sont-elles à risque ?\nLe stress peut-il aggraver l'hypersensibilité ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypersensibilité retardée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests cutanés spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de patch et les tests de stimulation lymphocytaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hypersensibilité retardée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et rougeurs apparaissent après exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des analyses sanguines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines ne sont pas spécifiques, mais peuvent aider à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les allergènes potentiels et les antécédents d'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruptions cutanées, démangeaisons, et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils immédiatement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils apparaissent généralement 24 à 72 heures après l'exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réaction cutanée ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réaction cutanée se manifeste par des rougeurs, des vésicules et un gonflement localisé."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypersensibilité retardée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition aux allergènes connus est la meilleure méthode de prévention."
}
},
{
"@type": "Question",
"name": "Les tests d'allergie aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests d'allergie peuvent identifier les allergènes à éviter pour prévenir les réactions."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme éviter certains aliments ou produits, peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les médicaments préventifs sont-ils disponibles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques peuvent être pris en prévention avant une exposition connue."
}
},
{
"@type": "Question",
"name": "Comment gérer les expositions accidentelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir un plan d'action et des médicaments d'urgence peut aider à gérer les expositions accidentelles."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'hypersensibilité retardée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal consiste en l'évitement de l'allergène et l'utilisation de corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les antihistaminiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antihistaminiques peuvent soulager les démangeaisons, mais ne traitent pas la cause."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes réduisent l'inflammation et soulagent les symptômes cutanés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements topiques recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crèmes ou pommades corticostéroïdes peuvent être appliquées sur les zones affectées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections cutanées peuvent survenir si les lésions sont grattées."
}
},
{
"@type": "Question",
"name": "L'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions répétées peuvent contribuer à des maladies cutanées chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'anaphylaxie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anaphylaxie est rare dans l'hypersensibilité retardée, mais des réactions sévères peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent entraîner des douleurs, des démangeaisons et une gêne sociale."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une hospitalisation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, une hospitalisation peut être nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'exposition répétée et la génétique sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypersensibilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les professions exposées sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines professions, comme celles en contact avec des produits chimiques, présentent un risque accru."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypersensibilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter la sensibilité aux allergènes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial d'allergies peut augmenter le risque d'hypersensibilité retardée."
}
}
]
}
]
}
Plant cells can undergo regulated cell death in response to exogenous factors (often in a stress context), but also as regular element of development (often regulated by phytohormones). The cellular a...
As a type of central nervous system tumor, meningioma usually compresses the nerve center due to its local expansion, further causing neurological deficits. However, there are limited therapeutic appr...
Bladder carcinoma is one of the most common malignancies worldwide, and >90% of all bladder cancers are classified as urothelial carcinomas (UC). Surgery, radiotherapy, chemotherapy, targeted therapy,...
This study examines the potential of herniarin from tarragon, as an agent with multifaceted effects on bladder cancer cells and investigates herniarin's impact on cell viability, migration, cell cycle...
Esophageal squamous cell carcinoma (ESCC) is a common digestive cancer with high mortality rate due to late diagnosis and drug resistance. It is important to identify new molecular target and develop ...
Targeting breast cancer stem cells with the CD44+/CD24- phenotype is critical for complete eradication of cancer cells due to its Self-renewal, differentiation, and therapeutic resistance ability. Que...
The human breast cancer cell line T47D was used for this experiment. T47D CSCs were isolated by magnetic bead sorting using the MACS system. The anticancer activity of Quercetin and Doxorubicin alone ...
We have shown that almost 1% of T47D cell populations are made up of CD44+/CD24- cells, which considered as cancer stem cells. Quercetin and Doxorubicin alone or in combination inhibited cell prolifer...
These outcomes suggested that CSCs are a minor population of cancer cells, which play a significant role in drug resistance by being quiescent, slow cycling and resistance to apoptosis. Furthermore, o...
Cells exposed to environmental stress arrest the cell cycle until they have adapted to their new environment. Cells adjust the length of the arrest for each unique stressor, but how they do this is no...
Therapy resistance in cancer is often driven by a subpopulation of cells that are temporarily arrested in a non-proliferative G0 state, which is difficult to capture and whose mutational drivers remai...
We develop methodology to robustly identify this state from transcriptomic signals and characterise its prevalence and genomic constraints in solid primary tumours. We show that G0 arrest preferential...
We propose a G0 arrest transcriptional signature that is linked with therapeutic resistance and can be used to further study and clinically track this state....
Age is a major risk factor for the acute and chronic complications of cancer chemotherapy. The current approach to the prevention of these complications is reactive and involves the reduction of the d...
molecular biology has revealed that different checkpoints control the proliferative cycle of normal and neoplastic cells. Two new drugs, Trilaciclib and ALRN-6924 may cause a temporary cell cycle arre...
In three randomized controlled phase II trials Trilaciclib proved effective in preventing neutropenia, thrombocytopenia and anemia in patients with non small cell lung cancer with non proficient RB1 g...
To prevent chromosome mis-segregation, a surveillance mechanism known as the spindle checkpoint delays the cell cycle if kinetochores are not attached to spindle microtubules, allowing the cell additi...